MLC Dx Raises $6M in Private Financing | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – San Francisco molecular diagnostics firm MLC Dx has raised almost $6 million in a private financing, it disclosed in a document filed with the US Securities and Exchange Commission this week.

The amount raised is part of an offering that seeks to raise a total of $9.7 million, according to the company's filing, which also stated that the offering comprised of equity, options, warrants, and other rights to acquire another security.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.